Literature DB >> 4974220

Structure and species as factors affecting the metabolism of some methoxy-6-sulphanilamidopyrimidines.

J W Bridges, M R Kibby, S R Walker, R T Williams.   

Abstract

1. A comparative study was made in man, rhesus monkey, rat and rabbit of the urinary excretion of 2-, 4- and 5-methoxy- and 2,4-, 2,5- and 4,5-dimethoxy-6-sulphanilamidopyrimidines given orally. 2. In the rabbit, 70-80% of the dose of each drug was excreted in 2 days, mainly as N(4)-acetyl derivatives, except 2,5-dimethoxy-6-sulphanilamidopyrimidine, which was mainly excreted unchanged. 3. In the rat, 50-70% of the dose of each drug was excreted in 2 days, except the 2-methoxy and 2,4-dimethoxy compounds, whose excretion was about 30%. The N(4)-acetyl derivatives accounted for 20-70% of the drugs excreted, except the 2,5-dimethoxy derivative, which was excreted unchanged. 4. In the rhesus monkey, some 40-60% of the dose of the 2-methoxy, 2,4-dimethoxy and 2,5-dimethoxy compounds was excreted in 2 days, but the 4-methoxy, 5-methoxy and 4,5-dimethoxy compounds were excreted at less than half this rate. The 4-methoxy, 5-methoxy and 4,5-dimethoxy compounds were highly acetylated (80-90%) whereas the 2-methoxy compound was poorly acetylated (17%) and the 2,5-dimethoxy compound hardly at all. The major metabolite of the 2,4-dimethoxy compound in the monkey was the N(1)-glucuronide. 5. In man, 30% of the dose of the 4-methoxy and 2,4-dimethoxy compounds was excreted in 24 hr., whereas the 4,5-dimethoxy compound (Fanasil) was very slowly excreted (12% in 2 days). The 4-methoxy compound was well acetylated (65%), but the 2,4- and 4,5-dimethoxy compounds were not (20-30%). The main metabolite of the 2,4-dimethoxy compound in man was the N(1)-glucuronide. 6. N(1)-Glucuronide formation occurred extensively only with the 2,4-dimethoxy compound and only in man and the rhesus monkey. It did not occur in the rabbit and only to a minor extent in the rat. 7. The 2,5-dimethoxy compound was not significantly acetylated in vivo in the rabbit, rat or monkey, but acetylation occurred in vitro in rabbit or monkey liver homogenates. 8. These findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4974220      PMCID: PMC1187803          DOI: 10.1042/bj1110167

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  5 in total

1.  The structure of the glucuronide of sulphadimethoxine formed in man.

Authors:  J W Bridges; M R Kibby; R T Williams
Journal:  Biochem J       Date:  1965-09       Impact factor: 3.857

2.  [Solution of pharmacological problems by computers. 7. An ALGOL-program for the Hückel method (HMO method) for the quantititive chemical determination of molecular states].

Authors:  E Krüger-Thiemer; R Hansen
Journal:  Arzneimittelforschung       Date:  1966-11

3.  Influence of acid-base balance on efficacy and toxicity of drugs.

Authors:  M D Milne
Journal:  Proc R Soc Med       Date:  1965-11

4.  Species differences in the metabolism and excretion of sulphasomidine and sulphamethomidine.

Authors:  J W Bridges; S R Walker; R T Williams
Journal:  Biochem J       Date:  1969-01       Impact factor: 3.857

5.  Species differences in the metabolism of sulphadimethoxine.

Authors:  J W Bridges; M R Kibby; S R Walker; R T Williams
Journal:  Biochem J       Date:  1968-10       Impact factor: 3.857

  5 in total
  3 in total

1.  Metabolites of sulphadimethoxypyrimidine in the urine of various species.

Authors:  S R Walker; R T Williams
Journal:  Biochem J       Date:  1969-12       Impact factor: 3.857

2.  The metabolism of four sulphonamides in cows.

Authors:  P Nielsen
Journal:  Biochem J       Date:  1973-12       Impact factor: 3.857

3.  Species differences in the aromatization of quinic acid in vivo and the role of gut bacteria.

Authors:  R H Adamson; J W Bridges; M E Evans; R T Williams
Journal:  Biochem J       Date:  1970-02       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.